Stephen Delaney
R&D
Associate Director, IMED Biotech Unit (Respiratory, Inflammation & Autoimmunity)
AstraZeneca
Philippines
Biography
Stephen obtained his PhD in Molecular Biology at Imperial College, London, before moving on to postdoctoral positions in Australia. He first identified the genes required for development of the Drosophila brain and then generated one of the first mouse models of cystic fibrosis with the same mutation as found in humans. This was followed by work on gene therapy for cystic fibrosis in a collaboration between Boehringer Ingelheim and the Medical Research Council (MRC) Human Genetics Unit in Edinburgh.
Research Interest
Respiratory, Inflammation & Autoimmunity
